The Sales and Marketing team at Calliditas Therapeutics is dedicated to promoting and commercializing Nefecon, a targeted treatment for IgA nephropathy. The team engages with healthcare professionals, manages relationships with key accounts, and ensures access to this innovative therapy for patients in need. Through strategic marketing initiatives and sales training, the team aims to effectively educate stakeholders about the benefits of Nefecon while navigating reimbursement challenges in the United States.
View all